WCN'21: Industry Symposia

Recorded On: 04/11/2021


Back to Package

WCN'21: Industry Symposia

Key:

Complete
Failed
Available
Locked
A Discussion With KDIGO: Individual Optimization of Management of CKD Patients with Diabetes and CVD Comorbidities (Boehringer Ingelheim & Lilly Alliance)
Open to view video.
Open to view video.
Why Target the Mucosal Immune System of the Gut to Treat IgA Nephropathy? (Calliditas Therapeutics)
Open to view video.
Open to view video.
Kidney Itch: What’s New and What to do (Connect2 CME/Vifor FMCRP)
Open to view video.
Open to view video.
SGLT2 Inhibitors: The Next Step to Optimal Care in CKD
Open to view video.
Open to view video.
New Insights in Alport Syndrome and Genetic Testing (Reata Pharmaceuticals)
Open to view video.
Open to view video.
Nonsteroidal MRAs: A New Chapter for the Management of CKD in T2D (Bayer AG)
Open to view video.
Open to view video.
The Challenge of Slowing Diabetic Kidney Disease Progression And Reducing Cardiovascular Risk: Recent Advances and Novel Strategies (Cardiometabolic Health Congress: Bayer Inc)
Open to view video.
Open to view video.
Contemporary Concepts in ADPKD: Innovations in Clinical Practice and Novel Disease Mechanisms (Sanofi Genzyme)
Open to view video.
Open to view video.
Examining Primary Hyperoxaluria Type 1 and Results From ILLUMINATE-A and ILLUMINATE-B Clinical Trials (Alnylam Pharmaceuticals)
Open to view video.
Open to view video.
Treating Anemia of CKD: Real-World Clinical Experience with HIF-PH Inhibitors
Open to view video.
Open to view video.
Proteinuria Treatment Targets in Glomerular Disease (Travere Therapeutics)
Open to view video.
Open to view video.